ALEXANDER SHERMAN

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease LOS ANGELES, CA NPI 1760864367

General Payments — all program years on this page

$6,383.74

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 105
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,129.24 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $2,660.001
Food and Beverage $469.2416

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $263.483
2020 $126.513
2021 $288.538
2022 $1,202.7331
2023 $1,373.2543
2024 $3,129.2417

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078869518 Actelion Pharmaceuticals US, Inc. $7.14 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078869704 Actelion Pharmaceuticals US, Inc. $26.38 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078869780 Actelion Pharmaceuticals US, Inc. $4.71 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078869990 Actelion Pharmaceuticals US, Inc. $149.63 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078870050 Actelion Pharmaceuticals US, Inc. $21.02 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078870064 Actelion Pharmaceuticals US, Inc. $27.86 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078870150 Actelion Pharmaceuticals US, Inc. $27.53 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078870172 Actelion Pharmaceuticals US, Inc. $24.08 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078870254 Actelion Pharmaceuticals US, Inc. $1.17 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078870292 Actelion Pharmaceuticals US, Inc. $2.67 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086172516 Bayer Healthcare Pharmaceuticals Inc. $29.80 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086192768 Bayer Healthcare Pharmaceuticals Inc. $16.68 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086203951 Bayer Healthcare Pharmaceuticals Inc. $28.82 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086230720 Bayer Healthcare Pharmaceuticals Inc. $34.05 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144509258 MITSUBISHI TANABE PHARMA AMERICA, INC. $2,660.00 04/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1149449944 United Therapeutics Corporation $34.65 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149465260 United Therapeutics Corporation $33.05 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.